Completed PHASE3 INTERVENTIONAL 1-arm NCT01251666

Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening (HeMO)

Comparison of Performances of Two Automated Immunochemical Faecal Occult Blood Tests in Colorectal Cancer Screening, in Reference to Usual Care Guaiac Test

Sponsor: Ligue contre le cancer, France

Conditions Colorectal Cancer

Interventions Colonoscopy

Updated 6 times since 2017 Last updated: Aug 31, 2012 Started: Jun 30, 2008 Primary completion: Jun 30, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Colorectal Cancer and is currently completed. Ligue contre le cancer, France leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ligue contre le cancer, France
National Cancer Institute, France
University Hospital, Caen

Data source: University Hospital, Caen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Moulins, France
• Saint-Doulchard, France